Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia

Experimental Hematology

Volumn 29, Issue 11, 2001, Pages 1270-1277

  Kook, Hoon ^a   Zeng, Weihua ^a   Guibin, Chen ^a   Kirby, Martha ^a   Young, Neal S ^a   Maciejewski, Jaroslaw P ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; GRANZYME B; IMMUNOSUPPRESSIVE AGENT; PERFORIN;

ANTIGEN SPECIFICITY; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNITY; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; CELL POPULATION; CELL SPECIFICITY; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC VALUE; DISEASE SEVERITY; EFFECTOR CELL; FLOW CYTOMETRY; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MOLECULAR SIZE; MYELODYSPLASIA; PANCYTOPENIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ANEMIA, APLASTIC; ANTIGENS, CD28; ANTIGENS, CD57; ANTIGENS, CD8; BIOLOGICAL MARKERS; CELL SEPARATION; COMPLEMENTARITY DETERMINING REGIONS; FLOW CYTOMETRY; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GRANZYMES; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOPHENOTYPING; MEMBRANE GLYCOPROTEINS; MYELODYSPLASTIC SYNDROMES; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, REGULATORY;

EID: 0034765667     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00736-6     Document Type: Article

References (53)

1. An increased HLA DR2 frequency is seen in aplastic anemia patients
2. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and PNH/aplastic anemia syndrome
3. Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia
4. Effect of peripheral blood mononuclear cells from aplastic anemia patients on the granulocyte-macrophage and erythroid colony formation in samples from normal human bone marrow in vitro - A cooperative work
5. Analysis of lymphocyte subsets in patients with aplastic anaemia
6. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure
7. Circulating activated suppressor T lymphocytes in aplastic anemia
8. Analysis of T-cell clonality in bone marrow of patients with acquired aplastic anaemia
9. Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: Evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia
10. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo
11. γ-interferon gene expression in the bone marrow of patients with aplastic anemia
12. Type I and type II T-cell profiles in aplastic anemia and refractory anemia
13. + T cells contain greatly expanded functional virus-specific memory CTL clones
14. + memory T lymphocytes in the peripheral blood of multiple sclerosis patients
15. + T-cell development
16. -progeny, but IL-4 prevents loss of CD28 expression
17. Loss of CD28 expression on T lymphocytes: A marker of replicative senescence
18. + T cells
19. Requirement for CD28-dependent T cell-mediated cytotoxicity
20. + T-cell population
21. - T cell expansion anergy or activation?
22. - T cells in healthy aging people, including centenarians
23. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes
24. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-vs-host disease after murine bone marrow transplantation
25. B cell repertoire diversity and clonal expansions in normal and clinical samples
26. + expansions in all healthy young adults
27. Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria
28. Oligoclonal T cell expansion in myelodysplastic syndrome: Evidence for an autoimmune process
29. Selection of patients for bone marrow transplantation in severe aplastic anemia
30. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia
31. Clinical features of the relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria
32. Proposals for the classification of the myelodysplastic syndromes
33. Increased apoptosis in aplastic anemia bone marrow progenitor cells: Possible pathophysiologic significance
34. + cells of patients with aplastic anaemia
35. Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition
36. Uncontrolled triggering of programmed cell death (apoptosis) in haematopoietic stem cells: A new hypothesis for the pathogenesis of aplastic anemia
37. Perforin-dependent nuclear targeting of granzymes: A central role in the nuclear events of granule-exocytosis-mediated apoptosis?
38. How do cytotoxic lymphocytes kill their targets?
39. Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis
40. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis
41. High numbers of perforin mRNA expressing CSF cells in multiple sclerosis patients with gadolinium-enhancing brain MRI lesions
42. Increased perforin expression in multiple sclerosis patients during exacerbation of disease in peripheral blood lymphocytes
43. The role of lymphotoxin in pathogenesis of polymyositis
44. Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes
45. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice
46. The role of phorbol ester-sensitive protein kinase C isoforms in lymphokine-activated killer cell-mediated cytotoxicity: Dissociation between perforin-dependent and Fas-dependent cytotoxicity
47. + T cell-mediated insulin-dependent diabetes mellitus
48. Tumor immunity in perforin-deficient mice: A role for CD95 (Fas/APO-1)
49. + T cells in organ-specific autoimmune disease: Insight from transgenic mouse models
50. Perforin gene defects in familial hemophagocytic lymphohistiocytosis
51. Antithymocyte globulin for patients with myelodysplastic syndrome
52. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome
53. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: Clinical and pathophysiological features